Adverse Event Reporting

VAERS ID	1445346
Gender	Female
Age
StateCode	FR
Pharmaceutical Company	PFIZER\BIONTECH
Lot Number
Number of vaccinations	2
Vaccinated	2021-06-14
Onset	2021-06-16
Condition	Died

Symptoms

• Pulmonary embolism

Current Illness

Preexisting Conditions

Medical History/Concurrent Conditions: Asthma; Factor II mutation (genetic mutation of the g202 10 a gene (factor II) in the form of heterozygot diagnosed in 02Dec); Obesity; Thrombosis venous deep

Other Medications

CARDIOASPIRIN

Previous Vaccinations

Allergies

Laboratory Data

Write-up

Bilateral massive pulmonary embolia after two days after administration of anti-covid II dose vaccine; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-746030.
A 54-years-old female patient received BNT162B2 (COMIRANTY; Solution for injection; Lot number: unknown), dose 2 intramuscular on 14Jun2021 as 2nd single dose for COVID-19 immunization.
Medical history included asthma, deep vein thrombosis, obesity and genetic mutation of the g202 10 a gene (factor II) in the form of heterozygot diagnosed in 02Dec.
Concomitant medication included acetylsalicylic acid (CARDIOASPIRIN).
The patient experienced bilateral massive pulmonary embolia after two days after administration of COVID-19 2nd dose vaccine (pulmonary embolism) (death) on 16Jun2021.
The patient died on 17Jun2021.
It was not reported if an autopsy was performed.
No follow-up attempts are possible; batch/lot number cannot be obtained.
No further in-formation is expected.
; Reported Cause(s) of Death: Bilateral massive pulmonary embolia after two days after administration of anti-covid II dose vaccine